CGH
EBS icon

Crossmark Global Holdings’s Emergent Biosolutions EBS Stock Holding History

Crossmark Global Holdings’s Portfolio EBS Stock Details EBS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-4,790
Closed -$208K – 1354
2021
Q4 		$208K Sell
4,790
-4,190
-47% -$190K ﹤0.01% 1322
2021
Q3 		$450K Sell
8,980
-10
-0.1% -$606 0.01% 971
2021
Q2 		$566K Sell
8,990
-280
-3% -$18K 0.01% 853
2021
Q1 		$861K Buy
9,270
+190
+2% +$19.5K 0.02% 645
2020
Q4 		$814K Buy
9,080
+5,190
+133% +$476K 0.02% 632
2020
Q3 		$402K Sell
3,890
-350
-8% -$37.7K 0.01% 865
2020
Q2 		$335K Buy
4,240
+20
+0.5% +$1.49K 0.01% 952
2020
Q1 		$244K Sell
4,220
-110
-3% -$6.34K 0.01% 957
2019
Q4 		$234K Buy
4,330
+10
+0.2% +$542 0.01% 1264
2019
Q3 		$226K Sell
4,320
-100
-2% -$4.66K 0.01% 1205
2019
Q2 		$214K Buy
4,420
+10
+0.2% +$479 0.01% 1271
2019
Q1 		$223K Buy
4,410
+20
+0.5% +$1.18K 0.01% 1267
2018
Q4 		$260K Sell
4,390
-7,310
-62% -$471K 0.01% 1157
2018
Q3 		$770K Buy
11,700
+1,000
+9% +$58.4K 0.02% 717
2018
Q2 		$540K Buy
10,700
+520
+5% +$27.1K 0.01% 896
2018
Q1 		$536K Sell
10,180
-1,320
-11% -$65.8K 0.01% 872
2017
Q4 		$534K Buy
11,500
+4,390
+62% +$185K 0.01% 948
2017
Q3 		$288K Buy
+7,110
New +$257K 0.01% 1343
2016
Q3 		$288K Buy
+7,110
New +$207K 0.01% 1343

Other funds holding EBS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

Crossmark Global Holdings's EBS Position: Q1 2022 in Review

Crossmark Global Holdings sold out of Emergent Biosolutions (EBS) in Q1 2022, closing a stake of 4,790 shares — an estimated $208K sold.

Crossmark Global Holdings first reported a position in EBS in Q3 2016 and held it in 19 quarters. The position peaked at $861K in Q1 2021. 255 funds tracked by Wall St. Rank hold EBS as of Q1 2022.

  • Crossmark Global Holdings reported no remaining Emergent Biosolutions position as of Q1 2022 after selling out during the quarter.
  • Crossmark Global Holdings sold 4,790 Emergent Biosolutions shares in Q1 2022, an estimated $208K.
  • Crossmark Global Holdings first reported a position in Emergent Biosolutions in Q3 2016 and held it in 19 quarters.
  • Crossmark Global Holdings's Emergent Biosolutions position peaked at $861K in Q1 2021.
  • 255 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q1 2022.

Based on Crossmark Global Holdings's 13F filing for Q1 2022, filed 11 May 2022.